0001123292-18-000508.txt : 20180308
0001123292-18-000508.hdr.sgml : 20180308
20180308103300
ACCESSION NUMBER: 0001123292-18-000508
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180306
FILED AS OF DATE: 20180308
DATE AS OF CHANGE: 20180308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHANG LINDA L
CENTRAL INDEX KEY: 0001535179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32966
FILM NUMBER: 18675413
MAIL ADDRESS:
STREET 1: ONE PARK PLACE
STREET 2: STE 450
CITY: ANNAPOLIS
STATE: MD
ZIP: 21401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001360886
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 710881115
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
BUSINESS PHONE: 443-545-1819
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-03-06
0001360886
OSIRIS THERAPEUTICS, INC.
OSIR
0001535179
CHANG LINDA L
7015 ALBERT EINSTEIN DRIVE
COLUMBIA
MD
21046
0
1
0
0
Chief Financial Officer
Incentive Stock Option (right to buy)
8.95
2018-03-06
4
A
0
10000
0
A
2019-03-06
2028-03-05
Common Stock
10000
30000
D
25% of the shares underlying this option shall vest on each of March 06, 2019, March 06, 2020, March 06, 2021 and March 06, 2022, subject to Reporting Person's continued service through the applicable vesting date.
/s/ Linda L. Chang
2018-03-08